FDA invests in clinical trial data

Share this article:

The FDA is putting up to $37.5 million toward improving clinical trials. Regulatory Focus reports that the regulator announced the money will go toward the Clinical Trials Transformation Initiative based at Duke University.

RF notes that the site is of note because the CTTI “includes nearly every government healthcare agency, pharmaceutical company and trade group as members, as well as several medical device manufacturers.”

RF says the goal of the multi-million-dollar effort is to improve data-driven decision-making.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.